Feed - News and features

• UK's Mission divests kidney drug to Dimerix for $292m
  Mission Therapeutics has struck a deal...
• GSK abandons cough drug added in $2bn Bellus deal
  Three years after buying Bellus Health...
• Radiopharma firm AdvanCell raises $315m, and other financings
  This week's round-up of private...
• UK experts call for meningitis shots for all 15-year-olds
  All 15-year-olds in the UK should be...

News | PharmaTimes

• EpilepsyGTx and ClearPoint Neuro join forces on targeted therapy
• NICE backs finerenone for heart failure
• EC approves Erbitux combination for first‑line treatment of BRAF V600E‑mutant mCRC
• FDA approves Leqembi Iqlik subcutaneous initiation dose for Alzheimer’s disease
• SMC recommends VEOZA for moderate to severe menopausal vasomotor symptoms

• Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
• Efficacy of Acupuncture for Postoperative Urinary Retention Following Radical Hysterectomy for Cervical Cancer
• Quadro-Iliac Plane Block for Pain Control After Posterior Spinal Instrumentation Surgery
• Femoral Nerve Gliding Versus Lumbopelvic Manipulation in Management of Patellofemoral Pain Syndrome